Literature DB >> 10616044

Can reduced folic acid and vitamin B12 levels cause deficient DNA methylation producing mutations which initiate atherosclerosis?

P E Newman.   

Abstract

Atherosclerosis of the vascular system has classically been attributed to elevated serum cholesterol concentrations. Recently, it has been found that reduced serum levels of folic acid, vitamin B12, and vitamin B6 are related to the etiology of atherosclerosis and coronary heart disease. These deficiencies lead to inadequate production of S-adenosyl-methionine, creating a condition of hypomethylation. It is hypothesized that this causes hypomethylation of the DNA in cells in the arterial intima resulting in mutation and proliferation of smooth-muscle cells which lead to the formation of atheroma. It is further hypothesized that such action can be reversed by supraphysiological doses of these three vitamins to reduce or remove existing atheroma. It is recommended that all patients suffering from atherosclerosis and having deficiencies of any of these three vitamins and/or an elevation of serum homocysteine receive supplementation to prevent worsening of their condition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10616044     DOI: 10.1054/mehy.1998.0794

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  20 in total

Review 1.  DNA hypomethylation in the origin and pathogenesis of human diseases.

Authors:  Igor P Pogribny; Frederick A Beland
Journal:  Cell Mol Life Sci       Date:  2009-03-27       Impact factor: 9.261

Review 2.  TET2: A Novel Epigenetic Regulator and Potential Intervention Target for Atherosclerosis.

Authors:  Yami Liu; Wen Peng; Kai Qu; Xiaolong Lin; Zhaolin Zeng; Jiaojiao Chen; Dangheng Wei; Zuo Wang
Journal:  DNA Cell Biol       Date:  2018-04-13       Impact factor: 3.311

Review 3.  Clinical applications of epigenetics in cardiovascular disease: the long road ahead.

Authors:  Stella Aslibekyan; Steven A Claas; Donna K Arnett
Journal:  Transl Res       Date:  2014-04-08       Impact factor: 7.012

4.  Maternal exposure to soy diet reduces atheroma in hyperlipidemic F1 offspring mice by promoting macrophage and T cell anti-inflammatory responses.

Authors:  Ramona L Burris; Sarah C Vick; Branimir Popovic; Pamelia E Fraungruber; Shanmugam Nagarajan
Journal:  Atherosclerosis       Date:  2020-09-22       Impact factor: 5.162

Review 5.  Epigenetic reprogramming in atherosclerosis.

Authors:  Vincenzo Grimaldi; Maria Teresa Vietri; Concetta Schiano; Antonietta Picascia; Maria Rosaria De Pascale; Carmela Fiorito; Amelia Casamassimi; Claudio Napoli
Journal:  Curr Atheroscler Rep       Date:  2015       Impact factor: 5.113

6.  Chronic kidney disease in children and the role of epigenetics: Future therapeutic trajectories.

Authors:  Samuel N Uwaezuoke; Henrietta U Okafor; Vivian N Muoneke; Odutola I Odetunde; Chioma L Odimegwu
Journal:  Biomed Rep       Date:  2016-10-18

Review 7.  Beyond genetics: epigenetic code in chronic kidney disease.

Authors:  Rama S Dwivedi; James G Herman; Timothy A McCaffrey; Dominic S C Raj
Journal:  Kidney Int       Date:  2010-09-29       Impact factor: 10.612

8.  Association between chronic arsenic exposure and nutritional status among the women of child bearing age: a case-control study in Bangladesh.

Authors:  Abul H Milton; S M Shahidullah; Wayne Smith; Kazi S Hossain; Ziaul Hasan; Kazi T Ahmed
Journal:  Int J Environ Res Public Health       Date:  2010-07-02       Impact factor: 3.390

9.  Dietary folate and vitamin B12 supplementation and consequent vitamin deposition in chicken eggs.

Authors:  Chaiyapoom Bunchasak; Sompong Kachana
Journal:  Trop Anim Health Prod       Date:  2009-04-25       Impact factor: 1.559

10.  Association between blood pressure and DNA methylation of retrotransposons and pro-inflammatory genes.

Authors:  Stacey E Alexeeff; Andrea A Baccarelli; Jaana Halonen; Brent A Coull; Robert O Wright; Letizia Tarantini; Valentina Bollati; David Sparrow; Pantel Vokonas; Joel Schwartz
Journal:  Int J Epidemiol       Date:  2013-02       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.